About
Wayne Lin is a Senior Research Fellow in Microbiology at Monash University, specializing in antimicrobial resistance and pharmacometric approaches to infectious disease treatment. His research focuses on optimizing therapies against drug-resistant pathogens, particularly using bacteriophage and antibiotic combinations. Lin has contributed to projects such as the development of the PhageGE platform for bacteriophage genome analysis and translational research on personalized medicine for Alzheimer's disease.
He has been recognized with multiple awards including Chancellor's Letters of Commendation (2008-2009) and research scholarships (2009-2010). Lin's work spans peer-reviewed contributions in journals like GigaScience and Clinical Microbiology and Infection, emphasizing translational challenges in phage therapy and metabolomic insights into bacterial pathogenesis.
- Key Projects:
- "Applying a pharmacometric approach to achieve personalized medicine in Alzheimer's disease" (2024-2026)
- "Translation of phage-polymyxin combination therapy against pandrug-resistant Klebsiella pneumoniae" (2021-2024)
- Peer Review Roles: Involved with International Journal of Antimicrobial Agents, Infection and Drug Resistance, and others since 2017.
